Renovaro Biosciences Announces Results of Special Meeting of Shareholders
LOS ANGELES, Jan. 25, 2024 (GLOBE NEWSWIRE) — Renovaro Biosciences Inc. (NASDAQ:RENB) (the “Company”), a biotechnology corporation focusing on cell, gene, and immunotherapy, announced today the results of the Company’s Special Meeting of Shareholders held at 12:00 pm ET on January 25, 2024.
Related news for (RENB)
- Don’t Miss Out: MoBot’s Latest Stock Updates 06/11/25 07:00 AM
- Breaking News: MoBot’s Latest Update as of 06/11/25 06:00 AM
- MoBot’s Stock Market Highlights – 06/03/25 09:00 AM
- 24/7 Market News Snapshot 03 June, 2025 – Renovaro Inc. Common Stock (NASDAQ:RENB)
- Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform